Singapore Artificial Intelligence in healthcare - Canadian Technology Accelerator

With its National Artificial Intelligence (AI) Strategy 2.0 updated in late 2023, Singapore is becoming a global leader in adopting of AI in the healthcare sector. The Ministry of Health (MOH) has committed approximately C$200M over the next five years to integrate more AI technologies into the healthcare system.

From solutions such as Singapore Eye Lesion Analyser (SELENA+) that detects signs of diabetic retinopathy disease, to an AI model that transcribes 'Singlish' to emergency responders, these technologies aim to address broader challenges such as an ageing population, rising medical costs, and a healthcare labour shortage.

If you are looking to expand your business or explore new opportunities in Singapore, the Canadian Technology Accelerator (CTA) in Singapore invites you to join the business development program at no cost.^{Footnote *}

This is a not-to-be-missed opportunity for Canadian healthcare technology companies seeking new partnerships, customers and local business knowledge.

Apply now

Important dates

Benefits of joining

The CTA will give you:

• networking opportunities and a platform to present to potential buyers, strategic partners and investors in the Singapore healthcare ecosystems
• access to market intelligence and strategic guidance on entering the Singapore market
• personalized mentorship and coaching from our in-market experts
• a platform to validate and localize your go-to-market plans

Who should apply

Companies must be interested in expanding into Singapore or using it as a launchpad to grow in the Southeast Asian markets. We are looking for high-potential, scale-up stage companies with AI-powered solutions that improve clinical decision-making, enhance patient experience, and increase operational efficiencies across the entire healthcare process. This includes, but is not limited to:

• Screening and diagnosis
  • Early detection of prevalent diseases (e.g., cancers and heart diseases) and health issues in Singapore, leading to early interventions
  • Improving accuracy and speed in patient diagnosis (e.g., MRI and X-rays)
• Clinical treatments and follow-up care
  • Assisting decisions on drug prescriptions and predicting adverse drug reactions
  • Developing personalized treatment plans
  • Enhancing digital solutions (e.g., digital therapeutics) that enables patient monitoring and remote medical intervention
• Resource management in hospitals and healthcare settings
  • Inventory monitoring and forecasting
  • Automation for administrative tasks such as documentation and summarizing medical records
  • Reducing patient waiting and discharge times
  • Prediction of patient length of stay and bed management

What you need to apply

How the program works

The CTA program offers a mix of virtual sessions and in-person participation in an international tradeshow. The program includes:

• market briefings on doing business in Singapore
• in-market site visits and participation in AsiatechX from May 27 to 29, 2025
• an opportunity to pitch in front of a curated audience
• tailored mentorship and coaching
• Business-to-Business (B2B) match-making with business leads and investors 

Contact us

Learn more about the CTA by contacting:

Tom Chang
Trade Commissioner
Canadian Technology Accelerator: Singapore
Canada's Trade Commissioner Service
tom.chang@international.gc.ca